The use of Ginkgo Biloba for the prevention of chemotherapy-related cognitive dysfunction
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2015
At a glance
- Drugs EGb 761 (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 10 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2007 Status changed from recruiting
- 18 Dec 2005 New trial record.